We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
49 hedge funds and large institutions have $62.8M invested in Corvus Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
138% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 8
100% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 8
29% more funds holding
Funds holding: 38 → 49 (+11)
8% more capital invested
Capital invested by funds: $58.1M → $62.8M (+$4.74M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4.9% less ownership
Funds ownership: 58.13% → 53.24% (-4.9%)
80% less call options, than puts
Call options by funds: $93K | Put options by funds: $462K
Holders
49
Holders Change
+11
Holders Change %
+28.95%
% of All Funds
0.86%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
16
Reduced
8
Closed
8
Calls
$93K
Puts
$462K
Net Calls
-$369K
Net Calls Change
-$586K
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$4.64M |
| 2 |
O
OrbiMed
New York
|
+$4.64M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.29M |
| 4 |
Two Sigma Investments
New York
|
+$1.26M |
| 5 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
+$1.22M |
